Search all trials

Find therapies in clinical trials near you – page 801

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Squamous cell carcinoma

Not recruiting

Registered drug

Study of Pembrolizumab as Additional Treatment for Patients with High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma After Surgery and Radiation

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Hepatitis D

Not recruiting

Registered drugNo placebo

Study on Bulevirtide Treatment for Patients with Chronic Hepatitis D

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Bulevirtide

Contact Research Centre

Pulmonary hypertension

Not recruiting

Investigational

Study on the Safety and Effectiveness of MK-5475 for Adults with Pulmonary Hypertension and COPD

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:3-(4-{(5S)-4-Amino-2-[6-Chloro-1-(3,3,4,4,4-Pentafluorobutyl)-1H-Indazol-3-Yl]-5-Methyl-6-Oxo6,7-Dihydro-5H-Pyrrolo[2,3-D]Pyrimidin-5-Yl}Phenyl)Propanoic Acid

Contact Research Centre

Anaemia+1

Not recruiting

InvestigationalNo placebo

Study of AG-946 for Treating Anemia in Patients with Lower-Risk Myelodysplastic Syndromes

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Ag-946

Contact Research Centre

Lipoprotein metabolism disorder

Not recruiting

Investigational

Study of LY3819469 for Adults with High Lipoprotein(a) Levels

Investigational

Denmark

Participants:18–64 years · 65+ years
Substances:Ly3819469 Sodium

Contact Research Centre

Hormone-refractory prostate cancer+1

Not recruiting

Registered drug

Study of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Enzalutamide

Contact Research Centre

Liver disorder

Not recruiting

Registered drugNo placebo

Study on Orlistat's Effect on Liver Fat in Obese Patients with Non-Alcoholic Fatty Liver Disease and High Proneurotensin Levels

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Orlistat

Contact Research Centre

Obesity+1

Not recruiting

Registered drugNo placebo

Study Comparing Tirzepatide and Semaglutide for Weight Loss in Adults with Obesity or Overweight and Related Health Issues

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Ly3298176

Contact Research Centre

Non-small cell lung cancer stage I+1

Not recruiting

Registered drug

Study on the Safety and Effectiveness of Stereotactic Body Radiotherapy with or without Pembrolizumab for Patients with Unresected Stage I or II Non-Small Cell Lung Cancer

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Neoplasm malignant

Not recruiting

InvestigationalNo placebo

Study on the Safety of GEN1053 Alone and with an Immunomodulator for Patients with Malignant Solid Tumors

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Gen1053

Contact Research Centre

Autoimmune haemolytic anaemia+1

Not recruiting

Registered drugNo placebo

Study for Patients with Advanced Malignancies: Continued Treatment with Parsaclisib Alone or with Itacitinib, Ruxolitinib, Ibrutinib, or Tafasitamab

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Plasma cell myeloma refractory

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effectiveness of BCMACP03 for Patients with Relapsed or Refractory Multiple Myeloma

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Bcmacp03

Contact Research Centre

Find therapies in clinical trials near you – page 801

10 273 trials match your criteria

Squamous cell carcinoma

Study of Pembrolizumab as Additional Treatment for Patients with High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma After Surgery and Radiation

Hepatitis D

Study on Bulevirtide Treatment for Patients with Chronic Hepatitis D

Pulmonary hypertension

Study on the Safety and Effectiveness of MK-5475 for Adults with Pulmonary Hypertension and COPD

Anaemia+1

Study of AG-946 for Treating Anemia in Patients with Lower-Risk Myelodysplastic Syndromes

Lipoprotein metabolism disorder

Study of LY3819469 for Adults with High Lipoprotein(a) Levels

Hormone-refractory prostate cancer+1

Study of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Liver disorder

Study on Orlistat's Effect on Liver Fat in Obese Patients with Non-Alcoholic Fatty Liver Disease and High Proneurotensin Levels

Obesity+1

Study Comparing Tirzepatide and Semaglutide for Weight Loss in Adults with Obesity or Overweight and Related Health Issues

Non-small cell lung cancer stage I+1

Study on the Safety and Effectiveness of Stereotactic Body Radiotherapy with or without Pembrolizumab for Patients with Unresected Stage I or II Non-Small Cell Lung Cancer

Neoplasm malignant

Study on the Safety of GEN1053 Alone and with an Immunomodulator for Patients with Malignant Solid Tumors

Autoimmune haemolytic anaemia+1

Study for Patients with Advanced Malignancies: Continued Treatment with Parsaclisib Alone or with Itacitinib, Ruxolitinib, Ibrutinib, or Tafasitamab

Plasma cell myeloma refractory

Study on the Safety and Effectiveness of BCMACP03 for Patients with Relapsed or Refractory Multiple Myeloma

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.